Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
LymphomaCancer Survivors
Interventions
BEHAVIORAL

Lymfit exercise intervention

Participants randomized to this arm will be allocated a pre-registered Inspire II / Charge IV model Fitbit. The kinesiologist of the study will meet with the participants for a baseline fitness assessment. The kinesiologist will examine the baseline physical activity levels, fitness level and sedentary behaviours of the participants, to design a personalized exercise prescription. Within one week after the baseline fitness assessment, the kinesiologist will contact the participants to discuss the exercise prescription. Every two weeks there-after, the kinesiologist will follow up with the participants via videoconferencing to discuss their progress and to modify or advance their exercise prescriptions as needed. Participants will be followed-up at 6 months and 12 months.

BEHAVIORAL

Waitlist control

Participants will be contacted by the study kinesiologist for a baseline fitness assessment 3 months after they consent, participants will be given a Fitbit, a personalized exercise prescription and receive bi-weekly follow-ups for 12 weeks.

Trial Locations (1)

H3A 2A7

RECRUITING

Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

Jewish General Hospital

OTHER

collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

lead

McGill University

OTHER